Britt K. Erickson

Britt K. Erickson

Oncology
909 Fulton Street Southeast
Suite 202
Minneapolis, MN 55455

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Primary pelvic extraskeletal Ewing sarcoma: a case report and comprehensive literature review of molecularly confirmed cases arising within the female genital tract.

Primary pelvic extraskeletal Ewing sarcoma: a case report and comprehensive literature review of molecularly confirmed cases arising within the female genital tract.

Journal: Gynecologic oncology reports
Published: May 22, 2026

An analysis of the readability of Gynecologic Cancer patient education materials.

An analysis of the readability of Gynecologic Cancer patient education materials.

Journal: Gynecologic oncology
Published: April 08, 2026

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Journal: Gynecologic oncology
Published: March 19, 2026

Primary lymphatic leiomyosarcoma presenting as a pelvic mass.

Primary lymphatic leiomyosarcoma presenting as a pelvic mass.

Journal: Gynecologic oncology reports
Published: November 10, 2025

Oophorectomy-Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity.

Oophorectomy-Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity.

Journal: Cancer medicine
Published: October 25, 2025

Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV).

Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV).

Journal: Infectious agents and cancer
Published: September 23, 2025

STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancer.

STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancer.

Journal: BJC reports
Published: August 26, 2025

Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools.

Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools.

Journal: Molecular therapy. Oncology
Published: June 17, 2025

Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer.

Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 20, 2025

HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers.

HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers.

Journal: International journal of molecular sciences
Published: May 15, 2025

Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019.

Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019.

Journal: Gynecologic oncology
Published: March 19, 2025

Advances in the management of endometrial cancer.

Advances in the management of endometrial cancer.

Journal: BMJ (Clinical research ed.)
Published: March 05, 2025
Showing 1-12 of 74

Last Updated: 09/26/2026